Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.04.2015 | Case report

Temozolomide

Nausea, and hepatic enzymes elevation: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Gwak H-S, et al. Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytoma. Journal of Korean Neurosurgical Society 54: 489-495, No. 6, Dec 2013 - South KoreaCrossRefPubMedCentralPubMed Gwak H-S, et al. Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytoma. Journal of Korean Neurosurgical Society 54: 489-495, No. 6, Dec 2013 - South KoreaCrossRefPubMedCentralPubMed
Metadaten
Titel
Temozolomide
Nausea, and hepatic enzymes elevation: 2 case reports
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-0079-y

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Rituximab

Case report

Methylphenidate